Kenneth T. Mills
2016
In 2016, Kenneth T. Mills earned a total compensation of $2.7M as President and CEO at Regenxbio.
Compensation breakdown
| Non-Equity Incentive Plan | $206,000 |
|---|---|
| Option Awards | $1,979,413 |
| Salary | $514,890 |
| Other | $17,706 |
| Total | $2,718,009 |
Mills received $2M in option awards, accounting for 73% of the total pay in 2016.
Mills also received $206K in non-equity incentive plan, $514.9K in salary and $17.7K in other compensation.
Rankings
In 2016, Kenneth T. Mills' compensation ranked 3,580th out of 14,075 executives tracked by ExecPay. In other words, Mills earned more than 74.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,580 out of 14,075 | 75th |
Division Manufacturing | 1,248 out of 5,486 | 77th |
Major group Chemicals And Allied Products | 380 out of 1,900 | 80th |
Industry group Drugs | 277 out of 1,543 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 54 out of 287 | 81st |
Source: SEC filing on April 11, 2019.
Mills' colleagues
We found three more compensation records of executives who worked with Kenneth T. Mills at Regenxbio in 2016.